GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis.

Alessandro VillaschiGiuseppe FerranteFrancesco CannataDaniela PiniMatteo PagnesiElena CorradaBernhard ReimersRoxana MehranMassimo FedericiGianluigi SavareseMarco MetraGianluigi CondorelliGiulio Giuseppe StefaniniMauro Chiarito

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2024)

GLP1-ra do not decrease HF-hospitalization risk, despite a potential benefit in patients without history of HF, but are effective in reducing ischemic events irrespective of the presence of HF. PROSPERO-registered (CRD42022371264).

Keyphrases

heart failure
acute heart failure
end stage renal disease
rheumatoid arthritis
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
ankylosing spondylitis
type diabetes
adipose tissue
cardiac resynchronization therapy
skeletal muscle
patient reported outcomes